E-LIB Suche - Ergebnisse für: Princen, H.

1

SOC-V-09 Development of quantitative adverse outcome pathwa..:

Westerhout, J. ; Krishnan, S. ; Schillemans, T....
Toxicology Letters. 368 (2022) - p. S67 , 2022

Link: https://doi.org/10.1016/..

2

AAV5-based gene therapy targeting ANGPTL3 reduces hyperlipi..:

Zancanella, V. ; Valles-Sanchez, A. ; Tornero, C. Vendrell...
Atherosclerosis. 331 (2021) - p. e122-e123 , 2021

Link: https://doi.org/10.1016/..

3

P733Cholesterol uptake triggers macrophage proliferation in..:

Hilgendorf, I ; Haerdtner, C ; Kornemann, J...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

4

The Structurally Engineered Fatty Acid Icosabutate Improves..:

Stokman, G. ; van den Hoek, A. ; Pieterman, E....
Atherosclerosis. 287 (2019) - p. e55 , 2019

Link: https://doi.org/10.1016/..

5

The APOE*3Leiden.GK +/-mouse as novel translational model f..:

Pouwer, M. ; Heinonen, S. ; Behrendt, M....
Atherosclerosis. 252 (2016) - p. e226-e227 , 2016

Link: https://doi.org/10.1016/..

6

PO32 La réduction des VLDL-triglycerides plasmatiques par l..:

Geerling, J. ; van der Zon, G. ; van den Hoek, A....
Diabetes & Metabolism. 38 (2012) - p. A29 , 2012

Link: https://doi.org/10.1016/..

7

181 ADDITIVE EFFECTS OF NIACIN ON TOP OF SIMVASTATIN TREATM..:

Louwe, M. ; Kühnast, S. ; Smit, J....
Atherosclerosis Supplements. 12 (2011) 1 - p. 40 , 2011

Link: https://doi.org/10.1016/..

8

P181 - Effets hypocholestérolémiants de la metformine chez ..:

Geerling, J. ; van der Zon, G. ; Princen, H....
Diabetes & Metabolism. 37 (2011) 1 - p. A77 , 2011

Link: https://doi.org/10.1016/..

9

P28 RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMEN..:

Berbée, J. ; Wong, M.-C. ; Wang, Y....
Atherosclerosis Supplements. 11 (2010) 2 - p. 22 , 2010

Link: https://doi.org/10.1016/..

10

Abstract: P201 APOE*3LEIDEN.CETP TRANSGENIC MICE AS MODEL F..:

van Den Hoek, A ; van der Hoorn, J ; van Den Hoogen, C...
Atherosclerosis Supplements. 10 (2009) 2 - p. e520 , 2009

Link: https://doi.org/10.1016/..

11

Abstract: P479 RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS..:

Berbée, J ; Wong, M-C ; Wang, Y...
Atherosclerosis Supplements. 10 (2009) 2 - p. e791 , 2009

Link: https://doi.org/10.1016/..

12

Abstract: P984 PPAR Δ AGONIST GW501516 STRONGLY PREVENTS DE..:

van der Hoorn, J ; van Den Hoogen, C ; Pieterman, E.
Atherosclerosis Supplements. 10 (2009) 2 - p. e1138 , 2009

Link: https://doi.org/10.1016/..

13

Abstract: 533 BEXAROTENE INDUCES DYSLIPIDEMIA BY INCREASED ..:

de Vries-van der Weij, J ; de Haan, W ; Hu, L...
Atherosclerosis Supplements. 10 (2009) 2 - p. e275 , 2009

Link: https://doi.org/10.1016/..

14

Abstract: P202 APOE*3LEIDEN-HCETP MICE AS MODEL TO UNRAVEL ..:

van Den Hoek, A ; Baumeister, J ; Princen, H...
Atherosclerosis Supplements. 10 (2009) 2 - p. e521 , 2009

Link: https://doi.org/10.1016/..

15

Abstract: P980 PERFLUOROHEXANESULFONATE AND PERFLUOROOCTANE..:

Pieterman, E ; Rensen, P ; Maas, A...
Atherosclerosis Supplements. 10 (2009) 2 - p. e1134 , 2009

Link: https://doi.org/10.1016/..